| Identification | Back Directory | [Name]
2-Quinoxalineacetamide, N-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-3-oxo-1-(1-oxo-3-phenyl-2-propen-1-yl)- | [CAS]
1219439-82-3 | [Synonyms]
2-Quinoxalineacetamide, N-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-3-oxo-1-(1-oxo-3-phenyl-2-propen-1-yl)- | [Molecular Formula]
C25H19Cl2N3O3 | [MOL File]
1219439-82-3.mol | [Molecular Weight]
480.34 |
| Hazard Information | Back Directory | [Uses]
PTK7/β-catenin-IN-6 (Compound 03653) is an inhibitor for PTK7/β-catenin interaction, which inhibits the Wnt signaling pathway, and exhibits an anticancer activity against colorectal cancer (CRC)[1]. | [References]
[1] Ganier L, et al., Discovery of Small-Molecule Inhibitors of the PTK7/β-Catenin Interaction Targeting the Wnt Signaling Pathway in Colorectal Cancer. ACS Chem Biol. 2022 May 20;17(5):1061-1072. DOI:10.1021/acschembio.1c00826 |
|
|